Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


20.03.2017

4 Am J Ophthalmol
1 Ann Intern Med
1 BMC Ophthalmol
7 BMJ
1 Br J Ophthalmol
1 Clin Chem
4 Diabet Med
3 Diabetes
6 Diabetes Care
8 Diabetes Obes Metab
6 Diabetologia
2 Eur J Endocrinol
1 Invest Ophthalmol Vis Sci
2 J Diabetes Complications
1 J Nutr
1 JAMA
1 Lancet Diabetes Endocrinol
1 Metabolism
1 Ophthalmology
1 Pediatr Diabetes
1 PLoS Genet
10 PLoS One
2 Retina


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Ophthalmol

  1. DESAPRIYA E, Khoshpouri P, Al-Isa A
    Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial.
    Am J Ophthalmol. 2017 Mar 13. pii: S0002-9394(17)30068.
    PubMed     Text format    

  2. BEAULIEU WT, Bressler NM, Gross JG
    Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial.
    Am J Ophthalmol. 2017 Mar 11. pii: S0002-9394(17)30070.
    PubMed     Text format    

  3. OPHIR A
    Early and Long-term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data.
    Am J Ophthalmol. 2017 Mar 11. pii: S0002-9394(17)30069.
    PubMed     Text format    

  4. TRIPATHY K
    Intravitreal Bevacizumab for the Treatment of Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2017 Mar 10. pii: S0002-9394(17)30066.
    PubMed     Text format    


    Ann Intern Med

  5. CHAMBERLAIN JJ, Herman WH, Leal S, Rhinehart AS, et al
    Pharmacologic Therapy for Type 2 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes.
    Ann Intern Med. 2017 Mar 14. doi: 10.7326/M16-2937.
    PubMed     Text format     Abstract available


    BMC Ophthalmol

  6. MINAMI Y, Nagaoka T, Ishibazawa A, Yoshida A, et al
    Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema.
    BMC Ophthalmol. 2017;17:28.
    PubMed     Text format     Abstract available


    BMJ

  7. MAYOR S
    Gum disease is an early sign of diabetes, and tooth loss is associated with risk of dementia, studies find.
    BMJ. 2017;356:j1225.
    PubMed     Text format    

  8. BOUCAUD-MAITRE D
    Inclusion of the EXAMINE study in a meta-analysis of the addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia.
    BMJ. 2016;353:i3186.
    PubMed     Text format    

  9. TUFAN F, Soyluk O, Bahat G, Karan MA, et al
    Under-representation of frail older people in meta-analysis of dipeptidyl peptidase-4 inhibitors and hypoglycaemia.
    BMJ. 2016;353:i3183.
    PubMed     Text format    

  10. SALVO F, Moore N, Arnaud M, Robinson P, et al
    Authors' reply to Tufan and colleagues and Boucaud-Maitre.
    BMJ. 2016;353:i3188.
    PubMed     Text format    

  11. KMIETOWICZ Z
    Screen time of over three hours a day is linked to diabetes risk factors in children.
    BMJ. 2017;356:j1301.
    PubMed     Text format    

  12. DYER C
    Diabetologist and former journal editor faces charges of data fabrication.
    BMJ. 2017;356:j1348.
    PubMed     Text format    

  13. MAYOR S
    Half of NHS services do not provide recommended care for diabetic foot ulcers, shows audit.
    BMJ. 2017;356:j1274.
    PubMed     Text format    


    Br J Ophthalmol

  14. WANG LZ, Cheung CY, Tapp RJ, Hamzah H, et al
    Availability and variability in guidelines on diabetic retinopathy screening in Asian countries.
    Br J Ophthalmol. 2017 Mar 14. pii: bjophthalmol-2016-310002.
    PubMed     Text format     Abstract available


    Clin Chem

  15. LOOMIS SJ, Chen Y, Sacks DB, Christenson ES, et al
    Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.
    Clin Chem. 2017 Mar 9. pii: clinchem.2016.264135.
    PubMed     Text format     Abstract available


    Diabet Med

  16. SEIDU S, Davies MJ, Farooqi A, Khunti K, et al
    Integrated primary care: is this the solution to the diabetes epidemic?
    Diabet Med. 2017 Mar 10. doi: 10.1111/dme.13348.
    PubMed     Text format     Abstract available

  17. BREEZE PR, Thomas C, Squires H, Brennan A, et al
    Cost-effectiveness of population-based, community, workplace and individual policies for diabetes prevention in the UK.
    Diabet Med. 2017 Mar 10. doi: 10.1111/dme.13349.
    PubMed     Text format     Abstract available

  18. MORETON RB, Stratton IM, Chave SJ, Lipinski H, et al
    Factors determining uptake of diabetic retinopathy screening in Oxfordshire.
    Diabet Med. 2017 Mar 11. doi: 10.1111/dme.13350.
    PubMed     Text format     Abstract available

  19. HOLT RI
    Diabetes and risk.
    Diabet Med. 2017;34:459.
    PubMed     Text format    


    Diabetes

  20. JI L, Liu F, Jing Z, Huang Q, et al
    MICU1 Alleviates Diabetic Cardiomyopathy Through Mitochondrial Ca2+-dependent Antioxidant Response.
    Diabetes. 2017 Mar 14. pii: db161237. doi: 10.2337/db16-1237.
    PubMed     Text format     Abstract available

  21. TRIVEDI PM, Graham KL, Scott NA, Jenkins MR, et al
    Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in Non-Obese Diabetic Mice.
    Diabetes. 2017 Mar 14. pii: db161250. doi: 10.2337/db16-1250.
    PubMed     Text format     Abstract available

  22. DE S, Kuwahara S, Hosojima M, Ishikawa T, et al
    Exocytosis-Mediated Urinary Full-Length Megalin Excretion is Linked with the Pathogenesis of Diabetic Nephropathy.
    Diabetes. 2017 Mar 13. pii: db161031. doi: 10.2337/db16-1031.
    PubMed     Text format     Abstract available


    Diabetes Care

  23. JENSEN ML, Persson F, Andersen GS, Ridderstrale M, et al
    Incidence of Ketoacidosis in the Danish Type 2 Diabetes Population Before and After Introduction of Sodium-Glucose Cotransporter 2 Inhibitors-A Nationwide, Retrospective Cohort Study, 1995-2014.
    Diabetes Care. 2017 Mar 10. pii: dc162793. doi: 10.2337/dc16-2793.
    PubMed     Text format    

  24. HOLLANDER P, Bays HE, Rosenstock J, Frustaci ME, et al
    Coadministration of Canagliflozin and Phentermine for Weight Management in Overweight and Obese Individuals Without Diabetes: A Randomized Clinical Trial.
    Diabetes Care. 2017 Mar 13. pii: dc162427. doi: 10.2337/dc16-2427.
    PubMed     Text format     Abstract available

  25. SCHATZ D
    Erratum. 2016 Presidential Address: Diabetes at 212 degrees -Confronting the Invisible Disease. Diabetes Care 2016;39:1657-1663.
    Diabetes Care. 2017 Mar 16. pii: dc17er05a. doi: 10.2337.
    PubMed     Text format    

  26. MERINO J, Leong A, Posner DC, Porneala B, et al
    Genetically Driven Hyperglycemia Increases Risk of Coronary Artery Disease Separately From Type 2 Diabetes.
    Diabetes Care. 2017 Mar 15. pii: dc162625. doi: 10.2337/dc16-2625.
    PubMed     Text format     Abstract available

  27. MENKE A, Casagrande S, Aviles-Santa ML, Cowie CC, et al
    Factors Associated With Being Unaware of Having Diabetes.
    Diabetes Care. 2017 Mar 13. pii: dc162626. doi: 10.2337/dc16-2626.
    PubMed     Text format    

  28. SOLIMAN EZ, Backlund JC, Bebu I, Orchard TJ, et al
    Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
    Diabetes Care. 2017 Mar 16. pii: dc162050. doi: 10.2337/dc16-2050.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  29. VAN RAALTE DH, Verchere CB
    Improving glycemic control in type 2 diabetes: stimulate insulin secretion or provide beta-cell rest?
    Diabetes Obes Metab. 2017 Mar 14. doi: 10.1111/dom.12935.
    PubMed     Text format     Abstract available

  30. HEISE T, Norskov M, Nosek L, Kaplan K, et al
    Insulin degludec: lower day-to-day and within-day variability in pharmacodynamic response compared to insulin glargine U300 in type 1 diabetes.
    Diabetes Obes Metab. 2017 Mar 14. doi: 10.1111/dom.12938.
    PubMed     Text format     Abstract available

  31. GARG M, Ghanim H, Kuhadiya ND, Green K, et al
    Liraglutide acutely suppresses glucagon, lipolysis and ketogenesis in type 1 diabetes.
    Diabetes Obes Metab. 2017 Mar 17. doi: 10.1111/dom.12944.
    PubMed     Text format     Abstract available

  32. SALASTEKAR N, Desai T, Hauser T, Schaefer EJ, et al
    Salsalate Improves Glycemia in Overweight Persons With Diabetes Risk Factors of Stable Statin-Treated Cardiovascular Disease: a 30-month Randomized Placebo-Controlled Trial.
    Diabetes Obes Metab. 2017 Mar 14. doi: 10.1111/dom.12940.
    PubMed     Text format     Abstract available

  33. BOULANGER M, Al-Shahi Salman R, Kerssens J, Wild SH, et al
    Association between diabetes mellitus and incidence and case-fatality after stroke due to intracerebral haemorrhage: a retrospective population-based cohort study.
    Diabetes Obes Metab. 2017 Mar 9. doi: 10.1111/dom.12934.
    PubMed     Text format     Abstract available

  34. POZZILLI P, Norwood P, Jodar E, Davies MJ, et al
    A placebo-controlled, randomised trial of the addition of once weekly GLP-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9).
    Diabetes Obes Metab. 2017 Mar 14. doi: 10.1111/dom.12937.
    PubMed     Text format     Abstract available

  35. TERAUCHI Y, Yamada Y, Ishida H, Ohsugi M, et al
    The efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients aged 60 years or older with type 2 diabetes mellitus (START-J trial).
    Diabetes Obes Metab. 2017 Mar 9. doi: 10.1111/dom.12933.
    PubMed     Text format     Abstract available

  36. DU J, Liang L, Fang H, Xu F, et al
    Efficacy and Safety of Saxagliptin Compared with Acarbose in Chinese Patients with Type 2 Diabetes Mellitus Uncontrolled on Metformin Monotherapy: Results of a Phase IV Open-Label Randomized Controlled Study (The SMART Study).
    Diabetes Obes Metab. 2017 Mar 14. doi: 10.1111/dom.12942.
    PubMed     Text format     Abstract available


    Diabetologia

  37. FENG AL, Xiang YY, Gui L, Kaltsidis G, et al
    Paracrine GABA and insulin regulate pancreatic alpha cell proliferation in a mouse model of type 1 diabetes.
    Diabetologia. 2017 Mar 9. doi: 10.1007/s00125-017-4239.
    PubMed     Text format     Abstract available

  38. MULDER H
    Melatonin signalling and type 2 diabetes risk: too little, too much or just right?
    Diabetologia. 2017 Mar 16. doi: 10.1007/s00125-017-4249.
    PubMed     Text format     Abstract available

  39. MARSHALL SM
    Precision diabetes: a realistic outlook on a promising approach.
    Diabetologia. 2017 Mar 16. doi: 10.1007/s00125-017-4244.
    PubMed     Text format    

  40. FLOREZ JC
    Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
    Diabetologia. 2017 Mar 10. doi: 10.1007/s00125-017-4227.
    PubMed     Text format     Abstract available

  41. HANSEN TI, Olsen SE, Haferstrom EC, Sand T, et al
    Cognitive deficits associated with impaired awareness of hypoglycaemia in type 1 diabetes.
    Diabetologia. 2017 Mar 9. doi: 10.1007/s00125-017-4233.
    PubMed     Text format     Abstract available

  42. SIMMONS RK, Bruun NH, Witte DR, Borch-Johnsen K, et al
    Does training of general practitioners for intensive treatment of people with screen-detected diabetes have a spillover effect on mortality and cardiovascular morbidity in 'at risk' individuals with normoglycaemia? Results from the ADDITION-Denmark cl
    Diabetologia. 2017 Mar 9. doi: 10.1007/s00125-017-4230.
    PubMed     Text format     Abstract available


    Eur J Endocrinol

  43. CHEMAITILLY W, Cohen LE
    DIAGNOSIS OF ENDOCRINE DISEASE: Endocrine late-effects of childhood cancer and its treatments.
    Eur J Endocrinol. 2017;176:R183-R203.
    PubMed     Text format     Abstract available

  44. GIORDA CB, Carna P, Romeo F, Costa G, et al
    Prevalence, incidence, and associated co-morbidities of treated hypothyroidism. An update from a European population.
    Eur J Endocrinol. 2017 Feb 8. pii: EJE-16-0559. doi: 10.1530/EJE-16-0559.
    PubMed     Text format     Abstract available


    Invest Ophthalmol Vis Sci

  45. ZHUANG P, Muraleedharan CK, Xu S
    Intraocular Delivery of miR-146 Inhibits Diabetes-Induced Retinal Functional Defects in Diabetic Rat Model.
    Invest Ophthalmol Vis Sci. 2017;58:1646-1655.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  46. KOSIBOROD M, Gause-Nilsson I, Xu J, Sonesson C, et al
    Efficacy and safety of dapagliflozin in patients with type 2 diabetes and concomitant heart failure.
    J Diabetes Complications. 2017 Feb 10. pii: S1056-8727(16)30861.
    PubMed     Text format     Abstract available

  47. SINHA S, Saxena S, Prasad S, Mahdi AA, et al
    Association of serum levels of anti-myeloperoxidase antibody with retinal photoreceptor ellipsoid zone disruption in diabetic retinopathy.
    J Diabetes Complications. 2017 Feb 28. pii: S1056-8727(16)30496.
    PubMed     Text format     Abstract available


    J Nutr

  48. HEDEMANN MS, Hermansen K, Pedersen S, Bach Knudsen KE, et al
    Resistant Starch but Not Enzymatically Modified Waxy Maize Delays Development of Diabetes in Zucker Diabetic Fatty Rats.
    J Nutr. 2017 Mar 15. pii: jn243899. doi: 10.3945/jn.116.243899.
    PubMed     Text format     Abstract available


    JAMA

  49. LACY ME, Wellenius GA, Sumner AE, Correa A, et al
    Association of Sickle Cell Trait With Hemoglobin A1c in African Americans.
    JAMA. 2017;317:507-515.
    PubMed     Text format     Abstract available


    Lancet Diabetes Endocrinol


  50. Correction to Lancet Diabetes Endocrinol 2017; published online Jan 23. http://dx.doi.org/10.1016/S2213-8587(17)30014-1.
    Lancet Diabetes Endocrinol. 2017 Mar 10. pii: S2213-8587(17)30086.
    PubMed     Text format    


    Metabolism

  51. NATALI A, Baldi S, Bonnet F, Petrie J, et al
    Plasma HDL-cholesterol and triglycerides, but not LDL-cholesterol, are associated with insulin secretion in non-diabetic subjects.
    Metabolism. 2017;69:33-42.
    PubMed     Text format     Abstract available


    Ophthalmology

  52. IP MS, Zhang J, Ehrlich JS
    The Clinical Importance of Changes in Diabetic Retinopathy Severity Score.
    Ophthalmology. 2017 Mar 8. pii: S0161-6420(16)31292.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  53. ERIE C, Van Name MA, Weyman K, Weinzimer SA, et al
    Schooling diabetes: Use of continuous glucose monitoring and remote monitors in the home and school settings.
    Pediatr Diabetes. 2017 Mar 17. doi: 10.1111/pedi.12518.
    PubMed     Text format     Abstract available


    PLoS Genet

  54. ANDERSEN MK, Jorsboe E, Sandholt CH, Grarup N, et al
    Identification of Novel Genetic Determinants of Erythrocyte Membrane Fatty Acid Composition among Greenlanders.
    PLoS Genet. 2016;12:e1006119.
    PubMed     Text format     Abstract available


    PLoS One

  55. CHEN S, Feng B, Thomas AA, Chakrabarti S, et al
    miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes.
    PLoS One. 2017;12:e0173918.
    PubMed     Text format     Abstract available

  56. AMOUZOU C, Breuker C, Fabre O, Bourret A, et al
    Skeletal Muscle Insulin Resistance and Absence of Inflammation Characterize Insulin-Resistant Grade I Obese Women.
    PLoS One. 2016;11:e0154119.
    PubMed     Text format     Abstract available

  57. LENHARD T, Ott D, Jakob NJ, Pham M, et al
    Predictors, Neuroimaging Characteristics and Long-Term Outcome of Severe European Tick-Borne Encephalitis: A Prospective Cohort Study.
    PLoS One. 2016;11:e0154143.
    PubMed     Text format     Abstract available

  58. ELIASSON B, Rawshani A, Axelsen M, Hammarstedt A, et al
    Cephalic phase of insulin secretion in response to a meal is unrelated to family history of type 2 diabetes.
    PLoS One. 2017;12:e0173654.
    PubMed     Text format     Abstract available

  59. BALDUCCI S, D'Errico V, Haxhi J, Sacchetti M, et al
    Level and correlates of physical activity and sedentary behavior in patients with type 2 diabetes: A cross-sectional analysis of the Italian Diabetes and Exercise Study_2.
    PLoS One. 2017;12:e0173337.
    PubMed     Text format     Abstract available

  60. CHU YW, Wu WS, Hsu CF, Wang JJ, et al
    Bidirectional association between ESRD dialysis and diabetes: National cohort study.
    PLoS One. 2017;12:e0173785.
    PubMed     Text format     Abstract available

  61. ZIEGLER D, Winter K, Strom A, Zhivov A, et al
    Spatial analysis improves the detection of early corneal nerve fiber loss in patients with recently diagnosed type 2 diabetes.
    PLoS One. 2017;12:e0173832.
    PubMed     Text format     Abstract available

  62. NEEDELL JC, Dinarello CA, Ir D, Robertson CE, et al
    Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes.
    PLoS One. 2017;12:e0173968.
    PubMed     Text format     Abstract available

  63. DE MOURA-TONELLO SC, Porta A, Marchi A, de Almeida Fagundes A, et al
    Correction: Cardiovascular Variability Analysis and Baroreflex Estimation in Patients with Type 2 Diabetes in Absence of Any Manifest Neuropathy.
    PLoS One. 2017;12:e0174492.
    PubMed     Text format     Abstract available

  64. KUO CH, Chen SC, Fang CT, Nien FJ, et al
    Screening gestational diabetes mellitus: The role of maternal age.
    PLoS One. 2017;12:e0173049.
    PubMed     Text format     Abstract available


    Retina

  65. CHOI D, Park I, Kwon S
    Light Pipe Guard-Assisted Cataract Extraction in Combined Pars Plana Vitrectomy.
    Retina. 2016.
    PubMed     Text format    

  66. LI AL, Wykoff CC, Wang R, Chen E, et al
    ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics.
    Retina. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: